{"doc_desc":{"title":"Epidemiology and treatment patterns in Soft Tissue Sarcoma (STS): a retrospective analysis on French expert centers databases","idno":"FRESH-PEF73335-en","producers":[{"name":"Juliette LONGIN","affiliation":"MERCK SANTE"}]},"study_desc":{"title_statement":{"idno":"FRESH-PEF73335-en","IDno":{"metadata_no":[{"agency":"PEF","code":"73335"},{"agency":"FReSH","code":"FRESH-PEF73335"}]},"title":"Epidemiology and treatment patterns in Soft Tissue Sarcoma (STS): a retrospective analysis on French expert centers databases","alternate_title":""},"study_authorization":{"agency":[]},"authoring_entity":[{"name":"Binh Bui;NGUYEN","firstname":"Binh Bui","lastname":"NGUYEN","type":"investigator","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/01hq89f96","role":"organisation id"},{"title":"SIREN","uri":"263305823","role":"organisation id"}],"email":"","affiliationName":"CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX","PILabo":"","isContact":false},{"name":"Jean-Yves;BLAY","firstname":"Jean-Yves","lastname":"BLAY","type":"investigator","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/01cmnjq37","role":"organisation id"},{"title":"SIREN","uri":"779924133","role":"organisation id"}],"email":"jean-yves.blay@lyon.unicancer.fr","affiliationName":"CENTRE LEON BERARD","PILabo":"","isContact":true},{"name":"Jean-Michel;COINDRE","firstname":"Jean-Michel","lastname":"COINDRE","type":"investigator","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/02yw1f353","role":"organisation id"},{"title":"SIREN","uri":"781831714","role":"organisation id"}],"email":"J.Coindre@bordeaux.unicancer.fr","affiliationName":"INSTITUT BERGONIE","PILabo":"","isContact":true},{"name":"Simone;MATHOULIN-PELISSIER","firstname":"Simone","lastname":"MATHOULIN-PELISSIER","type":"investigator","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/02yw1f353","role":"organisation id"},{"title":"SIREN","uri":"781831714","role":"organisation id"}],"email":"simone.pelissier@u-bordeaux.fr","affiliationName":"INSTITUT BERGONIE","PILabo":"","isContact":true},{"name":"Axel;LE CESNE","firstname":"Axel","lastname":"LE CESNE","type":"investigator","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/0321g0743","role":"organisation id"},{"title":"SIREN","uri":"775741101","role":"organisation id"}],"email":"","affiliationName":"INSTITUT GUSTAVE ROUSSY (IGR)","PILabo":"","isContact":false},{"name":"Fran\u00e7oise;DUCIMETIERE","firstname":"Fran\u00e7oise","lastname":"DUCIMETIERE","type":"investigator","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/02vjkv261","role":"organisation id"},{"title":"SIREN","uri":"180036048","role":"organisation id"}],"email":"","affiliationName":"INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)","PILabo":"","isContact":false}],"oth_id":[{"name":"Partenariat public-priv\u00e9 : French Sarcoma Group (GFS) - MERCK","type":"collaboration"}],"production_statement":{"prod_place":"Epidemiology France Portal (PEF)","producers":[{"name":"GROUPE SARCOME FRANCAIS - GROUPE D'ETUDE DES TUMEURS OSSEUSES (GSF-GETO)","extlink":[{"title":"SIREN","uri":"750388860","role":"sponsor id"}],"role":"sponsor"}],"funding_agencies":[{"name":"MERCK SANTE","extlink":[{"title":"SIREN","uri":"572028033"}]}]},"distribution_statement":{"contact":[{"name":"Jean-Yves;BLAY","lastname":"BLAY","firstname":"Jean-Yves","type":"contact","email":"jean-yves.blay@lyon.unicancer.fr","affiliationName":"CENTRE LEON BERARD","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/01cmnjq37","role":"organisation id","title":"ROR"},{"uri":"779924133","role":"organisation id","title":"SIREN"}]},{"name":"Jean-Michel;COINDRE","lastname":"COINDRE","firstname":"Jean-Michel","type":"contact","email":"J.Coindre@bordeaux.unicancer.fr","affiliationName":"INSTITUT BERGONIE","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/02yw1f353","role":"organisation id","title":"ROR"},{"uri":"781831714","role":"organisation id","title":"SIREN"}]},{"name":"Simone;MATHOULIN-PELISSIER","lastname":"MATHOULIN-PELISSIER","firstname":"Simone","type":"contact","email":"simone.pelissier@u-bordeaux.fr","affiliationName":"INSTITUT BERGONIE","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/02yw1f353","role":"organisation id","title":"ROR"},{"uri":"781831714","role":"organisation id","title":"SIREN"}]}]},"study_info":{"keywords":[{"keyword":"Soft Tissue Sarcoma (STS)"}],"topics":[{"topic":"Oncology","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/5784b7f1-c7ce-49d9-9f38-aebcda0ff41d"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D008495"}]},{"topic":"Neoplasms","vocab":"cim-11","extLink":[{"uri":"http:\/\/id.who.int\/icd\/entity\/1630407678","title":"CIM-11"}]}],"purpose":"To describe the treatment patterns of advanced (unresectable locally advanced or metastatic) STS (including viscus sarcoma) patients in France. Secondary objectives: - To describe STS (including viscus sarcoma) patients characteristics (sociodemographic data, type of sarcoma, histological subtype, tumor location, stage of the disease etc). - To assess the STS (including viscus sarcoma) incidence in France - To describe STS diagnosis (anatomopathology double review) and treatment history - To describe the duration of the different treatments of STS disease","abstract":"","coll_dates":[{"start":"2012-01-01","end":"2013-01-01"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}}],"geog_coverage":"","analysis_unit":"Individuals","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"value\": \"Male\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008297\"\n            }\n        },\n        {\n            \"value\": \"Female\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D005260\"\n            }\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"value\": \"Young Adult (19 to 24 years)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D055815\"\n            }\n        },\n        {\n            \"value\": \"Adult (25 to 44 years)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000328\"\n            }\n        },\n        {\n            \"value\": \"Middle Aged (45 to 64 years)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008875\"\n            }\n        },\n        {\n            \"value\": \"Aged (65 to 79 years)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000368\"\n            }\n        },\n        {\n            \"value\": \"Aged, 80 and over (80 years and more)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000369\"\n            }\n        }\n    ],\n    \"level_type_clusion_I\": \"Patients population\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"Patients with a diagnosis of STS, aged > 18 years-old, registered in the Conticabase\\\/NetSarc\\\/RRePS databases between January, 1st 2012 and December, 31st 2013 by a French expert center participating in the study between January, 1st 2012 and December, 31st 2013.\",\n    \"clusion_E\": \"\"\n}","data_kind":"['Clinical data']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":""}},"study_development":{"development_activity":[]},"method":{"data_collection":{"time_method":"","frequency":"","sampling_procedure":"['{\"concept\":{\"vocabURI\":\"Other\",\"vocab\":\"CESSDA\"},\"value\":\"Other\"}']","sample_frame":{"frame_unit":{"unit_type":"['Through organizations (health services or institutions, schools, businesses, etc.)']"}},"coll_mode":["{\"concept\":{\"vocabURI\":\"SelfAdministeredQuestionnaire\",\"vocab\":\"CESSDA\"},\"value\":\"Self-administered questionnaire\"}"],"research_instrument":"Access on specific project only","sources":[],"target_sample_size":"[1000-10000[ individuals","response_rate":"Conticabase: N = 1099 \/ NetSarc: N= 4551 \/ RRePS: N=6812"},"method_notes":"Observational Study","study_class":"Unknown","notes":[{"subject":"research type","values":["Observational Study"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"value\":\"To be defined\",\"extLink\":[]}"},"dataset_use":{"restrictions":"","conditions":"","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":""}],"deposit_req":"","cit_req":""},"notes":""}},"additional":{"IsImport":true,"versionLang":"en","originLang":"en","autoTranslation":false,"status":"imported","creationDate":"21-06-2016","lastUpdatedAuto":null,"lastUpdatedManual":"07-07-2025","isContributorPI":false,"contributorName":"","contributorAffiliation":"","addTeamMember":"","obtainedAuthorization":{"otherAuthorizingAgency":[]},"relatedDocument":[],"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":["Industry"],"otherFundingAgentType":[""]},"sponsor":{"sponsorType":["Private non-profit"],"otherSponsorType":[""]},"governance":{"committee":true},"collaborations":{"networkConsortium":true},"theme":{"complementaryInformation":"","RareDiseases":""},"activeFollowUp":{"isActiveFollowUp":false,"followUpModeOther":""},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":"","allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[],"inclusionGroups":[],"collectionProcess":{"collectionModeDetails":"Extraction, treatment and analysis of the RRePS, NetSarc and Conticabase databases by the French Sarcoma Group (GFS)","collectionModeOther":""},"dataCollection":{"inclusionStrategyOther":"","samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"dataCollectionIntegration":{"isDataIntegration":false},"geographicalCoverage":{"geoDetail":"France"},"dataTypes":{"clinicalDataDetails":"Sociodemographic characteristics of patients; Sarcoma epidemiology (type of sarcoma) ; STS epidemiology (histological subtype, tumor location, tumor depth, grade, stage at diagnosis, stage); Diagnosis (anatomopathology double review by an expert center, initial diagnosis, confirmatory diagnosis; Unresecable locally advanced or metastatic STS (1st line systemic treatment, 1st line CT and drug type, diagnosis date of unresecable locally advanced\/metastatic stage, initiation date of the 1st line CT, date of progression after 1st line treatment, 2nd, 3rd and 4th line CT and drug type)","biologicalDataDetails":"","isDataInBiobank":false,"biobankContent":[],"biobankContentOther":"","dataTypeOther":""},"variableDictionnary":{"variableDictionnaryAvailable":"","variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":"","mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[]},"isHealthTheme":true,"fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}